Showing results (411-420 of 2,484) with videos related to

Sort By:
Pageof 249
Anticancer Research|January 19, 1999
Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acidW L Browne, W R Wilson, B C Baguley, et al.
Cancer Research|February 1, 1995
N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drugJ W Moselen, M P Hay, W A Denny, et al.
British Journal of Cancer|August 1, 1990
The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vesselsL J Zwi, B C Baguley, J B Gavin, et al.
Diabetes|January 1, 1976
Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relativesD M Molenaar, P J Palumbo, W R Wilson, et al.
American Journal of Clinical Pathology|March 1, 1985
Detection of viral and chlamydial antigens in open-lung biopsy specimensC A Gleaves, T F Smith, A D Wold, et al.
The Journal of Cardiovascular Surgery|August 22, 2000
Ross procedure for complex left ventricular outflow tract obstructionW R Wilson, G E Greer, D S Durzinsky, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acidF B Pruijn, M van Daalen, N H Holford, et al.
Mayo Clinic Proceedings|March 1, 1982
Management of complications of infective endocarditisW R Wilson, E R Giuliani, G K Danielson, et al.
The British Journal of Cancer. Supplement|July 1, 1996
Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1R M Batchelder, W R Wilson, M P Hay, et al.
Oncology Research|January 1, 1994
Correlation between immune and vascular activities of xanthenone acetic acid antitumor agentsL J Zwi, B C Baguley, J B Gavin, et al.
Pageof 249